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In the present study, we investigated the therapeutic effect of a classical TCM formula, Free Wanderer Powder (逍
遙散 xiāo yáo sǎn), in a breast cancer mouse model induced with estrogen-insensitive breast cancer 4T1 cells. 
Ovariectomized Balb/c mice (6-8 weeks) or sham mice were injected into the fourth mammary fat pad with 4T1 cells 
in which tumors were palpable 7 days after injection. On the eighth day, the mice were divided into 4 groups and tube-
fed daily with vehicle, Free Wanderer Powder (逍遙散 xiāo yáo sǎn) formula or tamoxifen for 28 days. Tumor growth 
inhibition and the decrease of the average tumor mass were most evident in mice treated with Free Wanderer Powder 
(逍遙散 xiāo yáo sǎn). Free Wanderer Powder (逍遙散 xiāo yáo sǎn) treatment significantly reduced Bcl-2 and elevated 
Bax and p53 protein expressions in breast cancer tumor. These results were further confirmed by immunohistochemisty. 
Tamoxifen could decrease spleen mass and Bcl-2 protein expression, increase the Bax protein expression as well as 
exert uterotrophic effects by increasing uterus index and inducing the gene expressions in the uterus. Taken together, 
these results show that Free Wanderer Powder (逍遙散 xiāo yáo sǎn) treatment induced apoptosis at protein level and 
inhibited the tumor growth in 4T1-induced ovariectomized Balb/c female mice, indicating the possibility of its future 
use for treatment of estrogen-insensitive breast caner.
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INTRODUCTION
Breast cancer is a malignant growth that begins in the 
tissues of the breast. It is the most common cancer in 
women (Jemal et al., 2003), and has been increasing in 
men (Bagchi, 2007). Although advances in screening, 
surgery, adjuvant radiation, and systemic therapies are 
in practice, there is no effective cure for patient with 
advanced stages of the disease, especially in cases of 
hormone-insensitive cancer (Bange et al., 2001). The 
use of complementary and alternative medicine (CAM) 
is very popular amongst cancer patients. Traditional 
Chinese medicine (TCM) is considered as one type 
of CAM in western countries. Because of the holistic 
This is an open access article under the CC BY-NC-ND license.
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approach in diagnostics and therapies being employed 
by the TCM practitioners, prevention and treatment of 
cancer by TCM become increasingly popular (Dy et al., 
2004; Frenkel et al., 2005). 
According to traditional Chinese medicine, breast 
cancer was described as “Rock in the breast”. According 
to the Chinese medicine practitioners, nipple belongs 
to the foot reverting yin liver channel (足厥陰肝經 
zú jué yīn gān jīng), and the breast belongs to the foot 
yang brightness stomach channel (足陽明胃經 zú yáng 
míng wèi jīng). The outer region of breast belongs to the 
foot lesser yang gallbladder channel (足少陽膽經 zú 
shào yáng dǎn jīng). They believed that the occurrence 
of breast cancer is due to the internal impairment of 
seven affects (七情 qī qíng), qi-blood vacuity (氣血兩
虛 qì xuè liǎng xū), liver depression and spleen vacuity 
(肝鬱脾虛 gān yù pí xū), obstruction of channels and 
network vessels (經絡阻滯 jīng luò zǔ zhì), phlegm 
and qi congestion (痰氣壅滯 tán qì yōng zhì), yang 
vacuity yin exuberance (陽虛陰盛 yáng xū yīn shèng). 
Therefore, the therapy prescribed by the Chinese 
medicine practitioners is to mainly course the liver (疏
肝 shū gān), supplement blood and boost qi (補血益氣 
bǔ xuè yì qì), clear heat and transform phlegm (清熱化
痰 qīng rè huà tán), fortify the spleen and harmonize the 
stomach (健脾和胃 jiàn pí hé wèi).
Free Wanderer Powder  (逍遙散 xiāo yáo sǎn) and 
modified Free Wanderer Powder  (逍遙散 xiāo yáo 
sǎn), such as supplemented Free Wanderer Powder (加
味逍遙散 jiā wèi xiāo yáo sǎn), are among the most 
commonly-used Chinese formulas in the clinic. The 
basic functions of these formulas include coursing the 
liver (疏肝 shū gān), promoting Liver qi (肝氣 gān 
qì) circulation, nourishing Liver blood (肝血 gān xuè) 
and fortify the spleen (健脾 jiàn pí). In the clinic, Free 
Wanderer Powder  (逍遙散 xiāo yáo sǎn) and modified 
Free Wanderer Powder  (逍遙散 xiāo yáo sǎn) can be 
applied to treat anemia, functional uterine bleeding, 
menopausal syndrome, hepatitis, chronic gastritis, 
pelvic inflammatory disease (Shi, 2004; Wen et al., 
2006; Nie and Wang, 2005). This formula is composed 
of Bupleuri Radix (柴胡 chái hú), Angelicae sinensis 
Radix (當歸 dāng guī), Paeoniae Radix Alba (白芍 bāi 
sháo), Atractylodis Macrocephale Rhizoma (白術  bāi 
shú), Poria (茯苓 fú líng), Glycyrrihizae Radix (甘
草 gān cǎo), mint (薄荷 bō hè) and roasted ginger (煨
薑 wēi jiāng).  Bupleuri Radix (柴胡 chái hú) is the 
most common herb for coursing the liver (疏肝 shū 
gān) and resolve depression (解鬱 jiě yù), and mint can 
boost the former function further. Both Paeoniae Radix 
Alba (白芍 bāi sháo) and Angelicae sinensis Radix (當
歸 dāng guī) can supplement the blood (補血 bǔ xuè). 
Atractylodis Macrocephale Rhizoma (白術 bāi shú), 
Poria (茯苓 fú líng) and Glycyrrihizae Radix (甘草 gān 
cǎo) can supplement qi (補氣 bǔ qì) and harmonize the 
spleen and stomach (調和脾胃 tiáo hé pí wèi).  
The 4T1 cells grow as adherent epithelial type 
in vitro, and are characterized as murine estrogen-
nonresponsive mammary carcinoma cells (American 
Type Culture Collection (ATCC) catalogue no. 
CRL-2539). When injected into Balb/c mice, 4T1 cells 
rapidly multiply resulting in highly metastatic tumors 
and serves as an animal model for human stage IV 
breast cancer (Aslakson and Miller, 1992; Banka, et 
al., 2006). According to our knowledge, no study has 
reported on the effect of Free Wanderer Powder (逍遙
散 xiāo yáo sǎn) formula on the development of 4T1 
cell induced breast cancer in Balb/c female mice. In 
the present study, we have employed mouse 4T1 breast 
caner cell to induce the cancer tumor in Balb/c mice 
that possesses intact immune system. The efficacies of 
Free Wanderer Powder (逍遙散 xiāo yáo sǎn) on breast 
cancer development were studied. Tamoxifen, a drug 
against hormone-dependent breast cancer and hormone 
insensitive breast cancer, was used as a control in our 
animal study. Furthermore, the uterotrophic effects of 
the formulae in vivo  were evaluated by using uterus 
index and the expression of estrogen related gene and 
protein in the uterus.
MATERIALS AND METHODS
Tumor development
Female Balb/c mice (6-8w) were purchased 
from the Laboratory Animal Services Center of the 
Chinese University of Hong Kong and pair-fed with 
phytoestrogen-free AIN-93 diet. Balb/c mice were 
subjected to ovariectomy to remove the influence of 
endogenous estrogen or sham operation. After surgery, 
mice were allowed to recover for 2 weeks. The 4T1 
murine mammary carcinoma cell line was kindly 
provided by Dr. Fred Miller (Barbara Ann Karmanos 
Cancer Institute, Detroit, MI). The 4T1 cells were grown 
in EMEM supplemented with 10% FBS and penicillin 
100 U/ml and streptomycin 100 g/ml (Invitrogen, 
Carlsbad, CA) at 37℃ in a humidified atmosphere of 
95% air and 5% CO2. Following a 2-week post-surgical 
recovery period, the OVX or sham mice were injected 
into the mammary fat pad with 1×105 viable 4T1 cells 
in a 10  l volume. Palpable tumors appeared in 7-8 days 
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(Lelekakis et al., 1999).
Preparation of Extracts of the XYS Decoction
Free Wanderer Powder (逍遙散 xiāo yáo sǎn) was 
composed of the following dried raw materials: 
120g of Bupleuri Radix (柴胡 chái hú), 120g of 
Angelicae sinensis Radix (當歸 dāng guī), 120g 
of Paeoniae Radix Alba (白芍 bāi sháo), 120g of 
Atractylodis Macrocephale Rhizoma (白術 bāi shú), 
120g of Poria (茯苓 fú líng), 60g of Glycyrrihizae 
Radix (甘草 gān cǎo), 4g of mint (薄荷 bō hè) and 4g 
of roasted ginger (煨薑 wēi jiāng). These herbs were 
authenticated by Dr. Sibao Chen of PearL Materia 
Development (Shenzhen) Ltd (Figure 1). Thin-layered 
chromatography (TLC) and high performance liquid 
chromatography (HPLC) analyses were conducted to 
confirm the compliance of the quality of the herbs with 
the China Pharmacopoeia (2010 version).  
The herbs were soaked for 20min and extracted with 
boiling water, 10:1 (v/w) for 2h. The water extract was 
collected and the residue was then added with water 
and boiled for another 1h. The water extract was again 
collected and combined with the first one, and then dried 
by freeze drying. The yield of the extraction was 26%.
The HPLC profile of XYS decoction (Figure 1) was 
developed using the following conditions.  The Agilent 
XDB C18 (250 × 4.6 mm, 5μm) column was used. The 
mobile phase consisted of acetonitrile (A) and 0.1% 
trifluoroacetic acid (B) with a gradient programme as 
follows: 2% of A at 0 min, 5% of A at 6 min, 20% of A 
at 20 min, 29% of A at 35 min, 80% of A at 45 min. The 
flow rate was 1.0 ml/min and the DAD detector was set 
at 280 nm.  
In vivo  administration of traditional Chinese 
medicine (TCM)
On the eighth day, primary tumor size was measured 
using calipers and the mice were randomly divided into 
4 groups: (1) Vehicle, (2) Tamoxifen (100 g/mice), (3) 
Free Wanderer Powder (逍遙散 xiāo yáo sǎn) formula 
(13.92g/kg body weight, decoction extract) and (4) 
Sham according to tumor size and body weight. Tumor 
growth and body weight were measured every 3 days 
upon the start of treatment and the tumor volume were 
estimated by using the formula (length×width2×20.5). 
According to the preliminary study, the mice would die 
when the tumor reached a weight of 1-2g by 28-33 days 
treatment. Thus, all mice were sacrificed after TCM 
treatment for 28 days. Tumor and uterus were collected 
and deep frozen by liquid nitrogen for both gene and 
protein expression. Part of the tumor tissue was used for 
immunohistochemistry analysis. 
Real time quantitative RT-PCR analysis
Total RNA was isolated from tumor and uterus using 
Trizol according to the manufacturer’s protocol. Total 
RNA was reverse-transcribed in 20 µl of a reaction 
mixture that contained reverse transcription buffer, 
deoxynucleotide triphosphate mixture, random primers 
and MultiScribeTM reverse transcriptase, using the 
High-Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems, Foster City, CA), at 25℃ for 10 
min, 37℃ for 2h and 85℃ for 5 sec. For the tumor, 
the target genes are Bcl-2, Bax, p53 and GAPDH. For 
the uterus, the target genes are ERa, C3 and GAPDH. 
The sequences of the PCR primers for these genes 
are listed in Table 1. PCR was carried out in 20 μl 
reaction mixture containing 10 μl iQTM SYBR Green 
Supermix (Bio Rad Laboratories, Hercules, CA) and 
0.5 μl of cDNA template. The PCR was performed in 
an ABI 7900HT Fast Real-Time PCR system (Applied 
Biosystems). Standard curves were generated using 
















Figure 1. HPLC fingerprint of Free Wanderer Powder ( 逍遙散 xiāo 
yáo sǎn) decoction extract
The Agilent XDB C18 (250 × 4.6 mm, 5 μm) column was used. The 
mobile phase consisted of acetonitrile (A) and 0.1% trifluoroacetic 
acid (B) with a gradient programme as follows: 2% of A at 0 min, 5% 
of A at 6 min, 20% of A at 20 min, 29% of A at 35 min, 80% of A at 
45 min. The flow rate was 1.0 ml/min and the DAD detector was set 
at 280 nm. Each peak represent the main active compounds in Free 
Wanderer Powder ( 逍遙散 xiāo yáo sǎn) decoction extract.
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serially diluted solutions of cDNA derived from control 
sample. The target gene transcripts in each sample were 
normalized on the basis of its GAPDH.
Immunoblotting
For the tumor, the target proteins are Bcl-2, Bax, p53 
and β-actin. Part of tumor were homogenized and lysed 
with Nonidet P-40 buffer (20 mM Tris-HCl, pH 7.5, 150 
mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 10% glycerol, 
1% Nonidet P-40) containing protease inhibitors 
(aprotinin 2 μg/ml, leupeptin 2 μg/ml, 1 mM PMSF) and 
phosphatase inhibitors (1 mM sodium orthovanadate, 
10 mM NaF). Lysates were centrifuged at 14,000 
rpm for 30 min at 4ºC and protein concentrations 
were analyzed by the method of Bradford (Bio-Rad, 
Hercules, CA, USA). Equal amounts of proteins (30 
μg) were separated by SDS-PAGE on 10 % reducing 
gels at a constant voltage (150V), and transblotted 
onto PVDF membranes (Immobilin-P, Millipore Corp., 
MA, U.S.A.). Immuno-detection was performed after 
blocking non-specific binding sites on the membrane 
with 5%-skimmed milk. The blots were probed with 
primary antibody as follows: anti-Bcl-2, Bax and 
p53 (diluted 1:1000; Santa Cruz Biotechnology, Inc., 
Santa Cruz, CA) or mouse anti-beta-actin (diluted 
1:2000; Abcam, Cambridge, UK). This was followed 
by incubation with the goat anti-rabbit or anti-mouse 
antibody conjugated with horseradish peroxidase 
(1:2000; Santa Cruz Biotechnology, Inc., Santa Cruz, 
CA) as the secondary antibody for 2h. The antigen-
antibody complexes were then detected with enhanced 
chemiluminescence (ECL) reagent and visualized by the 
Lumi-Imager using Lumi Analyst version 3.10 software 
(Roche, Mannheim, Germany).
Immunohistochemistry
P a r t  o f  t h e  t u m o r  t i s s u e  w a s  u s e d  f o r 
immunohistochemistry analysis. Fresh tissues were 
fixed in buffered formalin, processed into paraffin 
block and were subjected to 3sm sections by rotary 
microtome. The specimen cytosection slides were 
deparaffinized, rehydrated in water, incubated with 
0.3% H2O2 in methanol for 30min to block endogenous 
peroxidase activity and the antigen retrieval steps were 
followed. After blocking with 2-10% normal serum 
with 5% BSA in buffer for 10-20 min, the slides were 
incubated with primary antibody against Bcl-2, Bax 
and progesterone receptor (PR). The sections were then 
incubated with the appropriate biotinylated secondary 
antibody followed by peroxidase-conjugated ABC 
and 3, 3-diaminobenzidine (Dako, Carpinteria, CA). 
The sections were then counter-stained with Mayer 
haematoxylin. PR, Bcl-2 and Bax-2 immunoreactivity 
was visualized by diaminobenzidine (DAB). The 
positive cells were brown and three sections for each 
rat were used for counting in 400 fold × (40×objective) 
on an Olympus microscope. Negative control study was 
performed by the omission of the primary antibody.
Statistical analysis
The data were analyzed by the non-paired student’s 
t-test between control group and each treatment group. 
Results were reported as Mean ± SEM. A p-value < 0.05 
was considered statistically significant.
RESULTS
Effect of TCM treatment on breast cancer tumor 
growth in ovariectomized Balb/c mice
Tumor growth and body weight were measured 
every 3 days upon the start of treatment and the tumor 
volume were estimated by using the formula (length
×width2×0.5) (Figure 2A). Tumor growth inhibition 
was most evident in mice treated with Free Wanderer 
Powder (逍遙散 xiāo yáo sǎn)  in which the percentage 
of inhibition was around 21~35% from day 10 to day 
28 of the experiment. Tamoxifen treatment appeared 
to have no inhibitory effect for the tumor growth in 
ovariectomized Balb/c mice. After 28d of treatment, the 
tumor mass were calculated and the average tumor mass 
of Free Wanderer Powder (逍遙散 xiāo yáo sǎn)  treated 
mice was found to be smaller than that of the untreated 
group. While the average tumor weight of tamoxifen 
treated mice and sham group were not significantly 
different from the ovariectomized mice treated with 
vehicle (Figure 2B). Since 4T1 cells possess high 
metastatic characteristic, the spleen of 4T1-inoculated 
mice were examined for evidence of secondary cancer 
development. In the control group, the spleen mass 
became larger on day 28 of the experiment. Tamoxifen 
treatment significantly reduced the spleen mass when 
compared with the control group.  The inhibitory 
effect of Free Wanderer Powder (逍遙散 xiāo yáo 
sǎn)  treatment was also discovered even though the 
difference was not significant  (Figure 2C).
Effect of TCM on p53, Bax and Bcl-2 mRNA 
expression in breast cancer tumor obatined from 
young ovariecotmized Balb/c mice
To investigate if the mitochondrial apoptotic events 
were involved in inhibiting effect of TCM formula on 
breast cancer growth, we first evaluated the mRNA 
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Figure 2. Effect of Free Wanderer Powder ( 逍遙散 xiāo yáo sǎn) treatment on tumor size, tumor weight and spleen mass in young ovariectomized 
Balb/c mice
A.  Tumor growth and body weight will be measured every 3 days upon the start of treatment with vehicle (C), Tamoxifen (T), Free Wanderer Powder 
( 逍遙散 xiāo yáo sǎn) (X), and sham (S). The tumor volume were estimated by using the formula (length×width2×0.5) (n=9-14).
B.  Balb/c mice were sacrificed on day 28 and the mean tumor mass was calculated. C: ovariectomized (OVX) mice treated with vehicle, T: OVX 
mice treated with tamoxifen, X: OVX mice treated Free Wanderer Powder ( 逍遙散 xiāo yáo sǎn), S: sham mice treated with vehicle. *P<0.05, 
**P<0.01 vs control (n=9-14). 
C.  Spleen masses of Balb/c mice on day 28 of the experiment. C: ovariectomized (OVX) mice treated with vehicle, T: OVX mice treated with 





Figure 3. Effect of  Free Wanderer Powder ( 逍遙散 xiāo yáo sǎn) on p53, Bax and Bcl-2 mRNA expression in breast cancer tumor in young ovariectomized 
Balb/c mice
Young ovariectomized Balb/c mice were treated with either vehicle (C), Tamoxifen (T), Free Wanderer Powder ( 逍遙散 xiāo yáo sǎn) (X). Sham 
operated mice (S) were treated with vehicle. Upon sacrifice on day 28 of treatment, breast cancer tumors were obtained for study of p53 (A), Bax 
(B) and Bcl-2 (C) mRNA expressions. No significant changes were found for p53, Bax and Bcl-2 mRNA expressions between each treatment group 
(n=6-7).
expression levels of pro-apoptotic protein p53 and 
Bax and anti-apoptotic protein Bcl-2 in breast cancer 
tumor obtained from young Balb/c mice. Figure 3A 
shows Free Wanderer Powder (逍遙散 xiāo yáo sǎn) 
treatment could slightly but not significantly induce 
p53 gene expression.  No significant change was found 
for Bax gene expression in tumor tissue obtained 
from young Balb/c mice upon TCM treatment (Figure 
3B). Tamoxifen, Free Wanderer Powder  (逍遙散 
xiāo yáo sǎn) treatment could slightly decrease the 
Bcl-2 gene expression in breast cancer tumor obtained 
from ovariectomized mice, but the changes were not 
significant due to large sample variation  (Figure 3C). 
These results suggest that TCM did not inhibit the 
growth of breast cancer tumor via the alteration of 
mRNA expression of p53, Bax and Bcl-2 in tumor 
obtained from young ovariectomized Balb/c mice.
Effect of TCM on p53, Bax and Bcl-2 protein 
expressions in breast cancer tumor obtained from 
young ovariectomized Balb/c mice
P53 protein expression was significant increased 
in ovariectomized mice treated with Free Wanderer 
Powder (逍遙散 xiāo yáo sǎn) as well as in Sham group 
(Figure 4A). Bax protein expressions were elevated in 
the tumor obtained from tamoxifen or Free Wanderer 
Powder (逍遙散 xiāo yáo sǎn) treated ovariectomized 
mice. Ovary intact mice (sham group) had a higher Bax 
A. B. C.
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protein expression than the ovariectomized mice (Figure 
4B). Treatment of ovariectomized Balb/c mice with 
tamoxifen and Free Wanderer Powder (逍遙散 xiāo yáo 
sǎn) significantly reduced Bcl-2 protein expression in 
breast cancer tumor (Figure 4C). These results indicated 
that Free Wanderer Powder (逍遙散 xiāo yáo sǎn) might 
exert inhibitory effects on breast cancer tumor growth 
through its action on post-transcriptional regulation 
of proteins involved in the apoptotic pathways, 
including the upregulation of p53 and Bax protein and 
Figure 4. Effect of Free Wanderer Powder ( 逍遙散 xiāo yáo sǎn) on 
p53, Bax and Bcl-2 protein expression in breast cancer tumor in young 
ovariectomized Balb/c mice
Young ovariectomized Balb/c mice were treated with either vehicle 
(C), Tamoxifen (T), Free Wanderer Powder ( 逍 遙 散 xiāo yáo sǎn) 
(X). Sham operated mice (S) were treated with vehicle. Upon sacrifice 
on day 28 of treatment, breast cancer tumors were obtained for study 
of p53 (A), Bax (B) and Bcl-2 (A)  protein expressions. *P<0.05, 






Figure 5. Immunohistochemical detection of progesterone receptor 
(PR) (A) , Bax (B) and Bcl-2 (C)  protein expression in breast cancer 
tumor obtained from young ovariectomized Balb/c mice. Young 
ovariectomized Balb/c mice were treated with either vehicle (C), 
Tamoxifen (T), Free Wanderer Powder ( 逍遙散 xiāo yáo sǎn) (X) for 
28 days. Sham operated (Sham) Balb/c mice were treated with vehicle. 
*P<0.05, **P<0.01,*** P<0.001 vs control (n=5). The positive cells 
were brown and three sections for each rat were used for counting in 
400 fold < (40 objective) on an Olympus microscope.
C.
downregulation of Bcl-2 protein in the tumor.
Immunohistochemistry assay for tumor tissue
The protein expression levels of progesterone 
receptor (PR), pro-apoptotic protein Bax and anti-
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apoptotic protein Bcl-2 in breast cancer tumor were 
detected by using immunohistochemistry. PR protein 
expressions in tumor were elevated in the tamoxifen 
treated ovariectomized mice (Figure 5A). Bax protein 
expressions were significantly increased in the 
tamoxifen and Free Wanderer Powder (逍遙散 xiāo 
yáo sǎn) treated ovariectomized mice and Sham mice 
(Figure 5B). In contrast, Bcl-2 protein expression 
were decreased significantly in tumor obtained from 
tamoxifen and Free Wanderer Powder (逍遙散 xiāo 
yáo sǎn) treated ovariectomized mice (Figure 5C). 
These results confirmed our western blotting analysis 
that these formulae exerted inhibitory effects on tumor 
growth through the alteration of protein expression of 
Bax and Bcl-2 in tumor. Moreover, it appeared that 
tamoxifen could upregulate PR protein expression in 
ovariectomized mice.
Uterotrophic effect of TCM
To study if tamoxifen and TCM exerted trophic 
effect on uterus, the uterus to body weight ratio was 
determined. The uterine index was significantly reduced 
in ovariectomized mice, suggesting that the surgery was 
successful. Tamoxifen significantly increased the uterus 
index compared with the control group. In contrast to 
tamoxifen, Free Wanderer Powder (逍遙散 xiāo yáo 
sǎn) did not increase uterus index in OVX mice (Figure 
6).
Effect of TCM on ER alpha and C3 mRNA 
expressions  in uterus
To investigate the estrogenic effect of TCM in uterus 
of young Balb/c mice, the expression of estrogen 
regulated genes, ER and C3, were determined. 
Figure 6. Effect of Free Wanderer Powder ( 逍遙散 xiāo yáo sǎn)  on 
uterus index in young ovariectomized Balb/c mice 
Young ovariectomized Balb/c mice were treated with either vehicle 
(C), Tamoxifen (T), Free Wanderer Powder ( 逍 遙 散 xiāo yáo sǎn) 
(X) for 28 days. Sham operated (Sham) Balb/c mice were treated with 
vehicle. Uterus was collected and the uterine index or uterus/body 
weight ratio was calculated by normalizing the weight of uterus with 
the final body weight of mice. *P<0.05 vs control (n=5).
Tamoxifen treatment decreased ER gene expression 
and increased estrogen regulated gene C3 mRNA 
expression in young ovariectomized mice (Figure 7A & 
B). No significant changes were found in Free Wanderer 
Powder (逍遙散 xiāo yáo sǎn) treatment group. 
DISCUSSION
In the present study, a murine breast cancer (4T1 
cell line) model which stands for human stage IV 
breast cancer was established for the evaluation of 
the therapeutic actions of the classical TCM formula, 
namely Free Wanderer Powder  (逍遙散 xiāo yáo 
sǎn) in vivo . The results clearly showed that Free 
Wanderer Powder  (逍遙散 xiāo yáo sǎn) formula, but 
not tamoxifen, has inhibitory effect for 4T1-induced 
breast caner development in ovariectomized Balb/c 
mice. Free Wanderer Powder (逍遙散 xiāo yáo sǎn) 
could increase the expressions of pro-apoptotic protein 
p53 and Bax protein and decrease the expression of 
anti-apoptotic protein Bcl-2 protein in breast cancer 
tumor. Tamoxifen could increase PR, Bax and decrease 
Bcl-2 protein expression and reduce the spleen mass. 
Moreover, tamoxifen, but not Free Wanderer Powder 
(逍遙散 xiāo yáo sǎn) formula, exerted the uterotrophic 
effects by increasing uterus index and inducing the 
Figure 7. Effect of Free Wanderer Powder ( 逍 遙 散 xiāo yáo sǎn) 
on ER (A) and C3 (B) gene expressions in uterus of young 
ovariectomized Balb/c mice
Young ovariectomized Balb/c mice were treated with either vehicle 
(C), Tamoxifen (T), Free Wanderer Powder ( 逍 遙 散 xiāo yáo sǎn) 
(X), for 28 days. Sham operated (Sham) Balb/c mice were treated with 
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gene expressions in the uterus. These results suggest 
the apoptosis is involved in inhibitory effects of Free 
Wanderer Powder  (逍遙散 xiāo yáo sǎn) treatment on 
4T1 cell induced breast cancer tumor.
The efficacy of Free Wanderer Powder (逍遙散 xiāo 
yáo sǎn) formula against the 4T1 cell induced breast 
cancer was firstly evaluated by monitoring tumor growth 
and tumor weight. Tumor growth and body weight 
were measured every 3 days upon the start of treatment 
and the tumor volume were estimated by using the 
formula (length×width2×0.5). The tumor growth was 
significantly inhibited by Free Wanderer Powder  (逍
遙散 xiāo yáo sǎn) formula in which the percentage of 
inhibition was around 21~35% from day 10 to day 28 of 
the experiment. The mean tumor mass was found to be 
smaller than that of the untreated group. These results 
suggest that the Free Wanderer Powder (逍遙散 xiāo 
yáo sǎn) formula is effective in inhibiting the 4T1 cell 
induced breast cancer tumor in ovariectomized Balb/c 
mice.
Tamoxifen has been used to treat hormone-sensitive 
breast cancers since the 1971 (Wyld, et al., 1999). 
Recently, studies have demonstrated the tamoxifen is 
also effective in the treatment of hormone-insensitive 
breast cancer which in advanced stages and exerts 
inhibitory effect on tumor growth (Jordan, 1994; Ercoli 
et al., 1998). This anti-breast cancer drug could limit 
breast cancer growth and reduce the risk of breast cancer 
of women who are at increased risk of developing breast 
cancer. However, continuous use of the drug could 
stimulate breast cancer progression and induce strokes, 
uterine cancer, blood clots and cataracts (Fisher, 1998; 
Fisher, 2005). In the present study, our data has shown 
that treatment with tamoxifen has no inhibitory effect on 
tumor growth and mean tumor mass. In a similar study 
conduced by Xanthopoulos et al (Xanthopoulos et al., 
2005), tamoxifen treatment had no inhibitory effect on 
average tumor volume. The different degrees of 4T1 
metastasis occurring across the treatment groups may 
be monitored by the spleen mass (Xanthopoulos et al., 
2005). Tamoxifen treatment significantly reduced the 
spleen mass when compared with the untreated group, 
indicating the inhibitory effect of tamoxifen on tumor 
metastasis.
A var ie ty  of  ant i -cancer  agents  can  induce 
programmed cell death or apoptosis in tumor cells 
which leading to the regression of a cancerous tumor. 
The apoptosis process is modulated by various proto-
oncogenes. P53 was the first identified tumor suppressor 
gene to functionally promote cell cycle arrest and inhibit 
abnormal cell proliferation. Studies have demonstrated 
that p53 plays an important role in hormone-induced 
protection in mammary tumorigenesis (Sivaraman et 
al., 2001; Jerry et al., 2000). P53 knockout will cause 
spontaneous development of mammary tumor (Pati 
et al., 2004). Bax is a pro-apoptotic gene that acts as 
a critical downstream effector of the p53-mediated 
apoptotic pathway. Bax can accelerate cell death and 
inhibit the protective function of Bcl-2 (Cory and 
Adams, 2002; Emdadual, et al., 2003). Bax forms 
dimmers with Bcl-2 and plays an important role in 
regulating the nature of the apoptotic response (Zhao 
et al., 2007). The inhibitory effects of Free Wanderer 
Powder  (逍遙散 xiāo yáo sǎn) were accompanied 
by stronger induction of p53 and Bax as well as 
suppression of Bcl-2 protein expression in breast 
cancer tumor. The induction of Bax protein expression 
and suppression of Bcl-2 protein expression was also 
revealed by immunohistochemistry analysis. These 
results indicated that Free Wanderer Powder (逍遙散 
xiāo yáo sǎn) could trigger the apoptosis by enhancing 
the p53 and Bax protein expressions and decreasing the 
Bcl-2 protein expression. Free Wanderer Powder  (逍遙
散 xiāo yáo sǎn) formula might be useful for treatment 
of hormone insensitive breast cancer in postmenopausal 
women.
Our study indicated that Free Wanderer Powder  (逍
遙散 xiāo yáo sǎn) were superior to tamoxifen for 
treatment of hormone insensitive breast cancer. Our 
results showed that Free Wanderer Powder (逍遙散 
xiāo yáo sǎn) was effective in inhibiting the growth 
of breast cancer in ovariectomized Balb/c mice. 
Whereas, tamoxifen could not suppress 4T1 induced 
breast cancer growth even though the induction of Bax 
protein and suppression of Bcl-2 protein expression 
by tamoxifen was also observed in ovariectomized 
animals. Moreover, Free Wanderer Powder  (逍遙散 
xiāo yáo sǎn) exerted no estrogenic activities in uterus 
of ovariectomized mice. In contrast, tamoxifen exert 
undesirable uterotrophic effects in ovariectomized mice. 
The latter consistently increased uterus index, induced 
ER dependent C3 gene expression as well as suppressed 
ER mRNA expression in uterus of ovariectomized mice. 
Progesterone receptor (PR) status in the tumor was 
studied by immunohistochemistry as it is well accepted 
that PR positive tumor is slightly slower growing 
and has a better chance of responding to hormone-
suppression treatment compared with PR negative tumor 
(Anderson, 2002). Our results showed that tamoxifen 
treatment significantly increased PR protein expression 
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in breast cancer tumor.
The inability of tamoxifen to inhibit tumor growth in 
OVX mice triggered us to study if the inhibitory actions 
of tamoxifen on breast cancer depend on estrogen status 
of the animals. Further study will be performed to study 
the effect of tamoxifen on 4T1 cell induced breast 
cancer in ovary intact mice. 
Taken together,  these results show that Free 
Wanderer Powder (逍遙散 xiāo yáo sǎn) induced 
apoptosis and inhibited the 4T1-induced tumor growth 
in ovariectomized Balb/c mice. Tamoxifen had no 
inhibitory effect for the 4T1-induced tumor growth. 
Tamoxifen exerts uterotrophic effects in ovariectomized 
mice. Our study demonstrates that the established breast 
cancer animal model could be employed to determine 
the efficacy as well as mechanism of actions of different 
TCM formulae. These studies provide new information 
for designing novel breast cancer treatment based on 
Chinese medicine, in particular for postmenopausal 
women who are suffering from hormone insensitive 
breast cancer.
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